Danaher Corp.

DHR14 Dec 2024
Healthcare
$234.27
+0.00 (+0.17%)
Lowest Today
$232
Highest Today
$235.5
Today’s Open
$234.27
Prev. Close
$234.5
52 Week High
$281.43
52 Week Low
$221.83
To Invest in Danaher Corp.

Danaher Corp.

Healthcare
DHR14 Dec 2024
+0.00 (+0.17%)
1M
3M
6M
1Y
5Y
Low
$232
Day’s Range
High
$235.5
232
52 Week Low
$221.83
52-Week Range
52 Week High
$281.43
221.83
1 Day
-
1 Week
+2.06%
1 month return
-2.8%
3 month return
-14.39%
6 month return
-7.84%
1 Year return
+3.54%
3 Years return
-16.84%
5 Years return
+78.36%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
8.23
BlackRock Inc
7
State Street Corp
3.8
FMR Inc
3.27
Wellington Management Company LLP
3.23
Vanguard Total Stock Mkt Idx Inv
2.84
T. Rowe Price Associates, Inc.
2.83

Market Status

Fundamentals
Market Cap
170023.53 mln
PB Ratio
3.31
PE Ratio
44.42
Enterprise Value
184920.57 mln
Total Assets
84488 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research  collaboration  with Stanford  University's Department  of  Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
Organisation
Danaher Corp.
Employees
61000
Industry
Diagnostics & Research
CEO
Mr. Rainer M. Blair
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities